AmerisourceBergen, TrakCel debut platform to speed access to cell therapies
FierceBiotech, Ravi Nalliah
AmerisourceBergen and partner TrakCel rolled out a new platform designed to speed access to prescribed cell and gene therapies to patients. The platform is designed to provide visibility throughout a patient’s cell and gene therapy by combining TrakCel’s advanced therapy orchestration platform, Ocellos, and AmerisourceBergen’s Fusion system, which is a customer relationship management and support platform offered by the company’s Lash Group.
For the full article, please visit FierceBiotech.